A detailed history of Claris Financial LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Claris Financial LLC holds 901 shares of LLY stock, worth $777,436. This represents 0.59% of its overall portfolio holdings.

Number of Shares
901
Previous 924 2.49%
Holding current value
$777,436
Previous $763,000 7.99%
% of portfolio
0.59%
Previous 0.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 26, 2025

SELL
$713.71 - $898.95 $16,415 - $20,675
-23 Reduced 2.49%
901 $702,000
Q4 2024

Jun 16, 2025

BUY
$727.2 - $932.06 $671,932 - $861,223
924 New
924 $713 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $820B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Claris Financial LLC Portfolio

Follow Claris Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claris Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claris Financial LLC with notifications on news.